Clinical Trials Phase I and Phase IIA 2015

The early phases of a clinical trial are the most crucial. This is where the potential of a drug is evaluated and applied to the treatment at stake. However, they are also the most expensive and regulated portions of a trial. It can cost up to two billion dollars just to complete these early phases of a clinical trial, and sometimes, they are even bypassed. If this does not occur, and a drug does go through Phase I and Phase IIA, corners can be proactively cut in order to decrease costs, meet regulatory requirements and ensure efficacy.

Agenda
May 7, 2015
8:00AM – 9:00AM Registration Opens and Continental Breakfast
9:00AM – 9:15AM Co-Chairpersons' Opening Remarks
9:15AM – 10:00AM Highlighting Major Challenges in Early Clinical Development and Optimizing Strategies Behind Driving Efficiency
10:00AM – 10:45AM Conduct Clinical Trials Based on Local Patient Profiling
10:45AM – 11:15AM Networking and Refreshment Break
11:15AM – 12:00PM Case Study: Clinical Study Protocol Exploration in Early Phase Oncology Development
and much more...